Parallel Advisors »

Cns Pharmaceuticals shares owned by Parallel Advisors

Quarter-by-quarter ownership of Cns Pharmaceuticals shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $2 1 2.00

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Large Cap Etf (VV)
Blackrock U.s. Equity Factor Rotation Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Cvb Finl Corp Stock (CVBF)
Google Stock (GOOGL)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)

View all positions for Parallel Advisors

Top funds holding Cns Pharmaceuticals

Frigate Ventures
Tower Research Capital
Wells Fargo & Company
Morgan Stanley
Global Retirement Partners
Plante Moran Financial Advisors
Bank of America Corporation
Parallel Advisors

View all funds holding Cns Pharmaceuticals